Porton Pharma Solutions Ltd. (300363)
XSHE XSHE Primary Summary
300363 Chart
People also search for
Porton Pharma Solutions Ltd. (300363) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Porton Pharma Solutions Ltd. ever had a stock split?
Porton Pharma Solutions Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Nianfeng Ju CEO | XSHE Exchange | CNE100001S57 ISIN |
| CN Country | 4,214 Employees | 12 May 2026 Last Dividend | 26 Mar 2015 Last Split | - IPO Date |
Overview
Porton Pharma Solutions Ltd. is a prominent player in the pharmaceutical industry, specializing in the production and supply of various pharmaceutical components. Founded in 2005 and based in Chongqing, China, the company has a rich history of serving clients across China, the United States, and Europe. Originally known as Porton Fine Chemicals Ltd., it underwent a rebranding in January 2018 to better reflect its broadened capabilities and strategic focus, adopting the name Porton Pharma Solutions Ltd. This rebranding signified the company's evolution from a pure manufacturing entity into a comprehensive solutions provider in the pharmaceutical sector. Serving a global clientele, Porton Pharma Solutions Ltd. is dedicated to delivering high-quality products and services, cementing its position as a trusted partner in the pharmaceutical supply chain.
Products and Services
- Small Molecule Active Pharmaceutical Ingredients (APIs)
- Dosage Forms
- Biologics
Porton Pharma Solutions Ltd. specializes in the manufacture and supply of small molecule active pharmaceutical ingredients, which form the core active components in many drugs. These products are critical for the pharmaceutical industry, as they provide the essential therapeutic activity in a range of medications used to treat various diseases.
The company extends its expertise to the production of dosage forms. This includes the final form of a pharmaceutical product, such as tablets, capsules, and liquids, ready for consumption by patients. This service encompasses the entire process from the combination of active pharmaceutical ingredients with excipients, to the final packaging of the product.
Biologics represent a rapidly growing segment of Porton Pharma Solutions Ltd.'s product portfolio. These products include a wide range of products such as vaccines, blood components, and cells for therapy that are derived from living organisms. Biologics are complex in nature and require sophisticated technologies and processes for their development and manufacture, areas in which Porton Pharma Solutions has developed considerable expertise.
